Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)

192
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on ROCHE HOLDING LTD.
3d ago U.S. court denies Ranbaxy's bid to block launch of rival generics
5d ago Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies
6d ago Pfizer dampens Astra bid hopes with German Merck cancer deal
6d agoDJROCHE : Gets U.S. Approval for Avastin Treatment of Ovarian Cancer
11/14 ROCHE : FDA Approves Genentech’s Avastin (bevacizumab) Plus Chemotherapy t..
10/27 Weak Merck sales overshadow third quarter cost cuts
10/22 Roche to spend $3.2 billion on towering Basel base
10/22DJRoche to Spend CHF3 Billion in Research Center, Basel Headquarters
10/16 ROCHE : Pharmacyclics Enters Into Agreement with Roche to Evaluate IMBRUVICA® an..
10/16 New breast cancer drugs boost sales at Roche
10/15 ROCHE : FDA Approves Esbriet® (pirfenidone) for the Treatment of Idiopathic Pulm..
10/13DJRoche Holding 3Q 2014 -- Forecast
10/08 ROCHE : FDA Grants Priority Review for Genentech’s Lucentis in Diabetic Re..
10/08 NOVARTIS : Shareholder group critical as Roche and Novartis chiefs top Swiss pay..
09/29 ROCHE : Genentech :’s Investigational Combination of Cobimetinib Plus Zelb..
09/28 ROCHE : Genentech :’s Perjeta Regimen Extended the Lives of People With an..
09/24 Adaptimmune raises $104 million to develop immune-system cancer drugs
09/17 For Roche CEO, celebrating failure is key to success
09/16 Roche's $8 billion InterMune buy not a signal for more big deals
09/08 Cost a focus as GSK takes lead in new wave of biotech lung drugs
09/04 Roche rules out mega deals, open to smaller ones - paper
09/04 Ex-Genentech boss Levinson resigns from Roche's board
09/03 Google's Calico, AbbVie forge deal against diseases of aging
08/27 InterMune drug may offer big upside to Roche if aimed at liver
08/25DJMARKET SNAPSHOT : S&P 500 Jumps To Record Close Just Below 2,000
08/25 S&P 500 sets record high but fails to hold 2,000 mark
08/25DJMARKET SNAPSHOT : S&P 500 Jumps To Record Close Just Below 2,000
08/25DJMARKET SNAPSHOT : U.S. Stocks Rise; S&P 500 Tries To Close Above 2,000
08/25 ROCHE : Harwood Feffer LLP : Announces Investigation of Intermune, Inc.
08/25DJMARKET SNAPSHOT : U.S. Stocks: S&P 500 Leaps Over 2,000 For Intraday Record
08/25DJMARKET SNAPSHOT : S&P 500 Jumps Above 2,000 For Intraday Record
08/25DJMARKET SNAPSHOT : U.S. Stocks Gain; S&P 500 Nears 2,000
08/25DJMARKET SNAPSHOT : U.S. Stocks: Futures Higher As Draghi Lifts Europe
08/25DJMARKET SNAPSHOT : U.S. Stocks: Futures Higher As Draghi Lifts Europe
08/25DJMARKET SNAPSHOT : U.S. Stocks: Futures Higher As Draghi Lifts Europe
08/25 Roche to buy U.S. biotech firm InterMune for $8.3 billion
08/25 Roche to buy U.S. biotech firm InterMune for $8.3 billion
08/24 ROCHE : and InterMune Reach Definitive Merger Agreement
08/18DJZurich Stocks Mostly Higher; Swisscom Down -- Market Talk
08/18DJEUROPE MARKETS : United Internet, Roche Climb In European Trading
08/18DJEUROPE MARKETS : United Internet, Roche Climb In European Trading
08/18DJEUROPE MARKETS : United Internet, Roche Climb In European Trading
08/18DJEUROPE MARKETS : United Internet, Roche Climb In European Trading
08/18 CHUGAI PHARMACEUTICAL : Shares in Japan's Chugai surge on report of Roche buyout..
08/18DJEUROPE MARKETS : United Internet, Roche Climb In European Trading
08/15 Wall Street ends mixed, recovers from Ukraine-driven slide
08/15 CHUGAI PHARMACEUTICAL : Roche to offer $10 billion for rest of Chugai: Bloomberg
08/15DJU.K. Drug Panel Backs Gilead's Hepatitis Drug at a Discount
08/15DJU.S. HOT STOCKS : Hot Stocks to Watch
08/14 ROCHE : FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment o..
08/13DJInterMune Draws Bids from Sanofi, Roche, GlaxoSmithKline -Bloomberg
08/08 ROCHE : Genentech : Submits Supplemental Biologics License Application to FDA fo..
07/31 AstraZeneca steps up push into cancer immunotherapy
07/25DJDrug Companies Oppose Moves to Reimburse Off-Label Medicine
07/24 ROCHE : breast cancer drugs keep it on track to meet targets
07/24DJROCHE : Profit Dented by Currencies
07/22DJRoche Holding AG 1st Half 2014 -- Forecast
07/22 ROCHE : FDA Grants Genentech’s Avastin Priority Review for Recurrent Plati..
07/19DJRoche Not Interested in Large Acquisitions, Says CEO -- Report
07/19 Roche CEO plans to steer clear of big acquisitions
07/15 ROCHE : FDA Grants Genentech’s Avastin Priority Review for Certain Types o..
07/14 ROCHE : Genentech :’s Investigational Medicine Cobimetinib, Used in Combin..
07/02DJEUROPE MARKETS : Alcatel Higher In Europe, But Orange Shares Sour
07/02DJEUROPE MARKETS : Alcatel, Roche Up In Europe, But Orange Shares Sour
07/02 GLAXOSMITHKLINE : Cameron enlists ex-Goldman economist in global superbug fight
07/02 JOHNSON & JOHNSON : Roche to buy U.S. biotech firm Seragon for up to $1.7 billio..
07/02DJGenentech to Buy Seragon Pharma For up to $1.725 Billion
07/02DJROCHE : Genentech to Buy Seragon Pharmaceuticals for up to $1.725 Billion
07/02 ROCHE : Genentech : Announces Definitive Agreement to Acquire Seragon Pharmaceut..
07/01 Sanofi raises stake in Regeneron; shares jump
06/12 SPOOKED BY PROBES, PHARMA EXECUTIVES : should I leave China?
06/10 ROCHE : Health Canada Approves Roche's HPV Test for First-Line Primary Screening..
06/02 ROCHE : acquires DNA sequencing firm for up to $350 mln
06/02DJRoche Buys U.S. DNA Sequencing Firm
06/02DJRoche Buys U.S. DNA Sequencing Firm
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF